The firm recently acquired Collins Stewart Hawkpoint, a UK broker and the appointment of Rosnay is seen as part of the firm’s international expansion efforts, as reported by the Wall Street Journal.
Prior to BofA, Rosnay was the co-head of UK investment banking at Lazard and has advised health-care clients such as GlaxoSmithKline and Abbott Laboratories.
Rosnay also served at Lehman Brothers Holdings as co-head of European investment banking, before the firm filed bankruptcy in late 2008.
Rosnay is supposed to succeed Mark Brown, the former head of Collins Stewart, who had been the European CEO after the deal closed in March this year.
Canaccord was originally founded as a venture-capital firm in 1950 in western Canada and has expanded over the year through acquisitions including Boston-based Adams, Harkness & Hill Financial in 2006 and Genuity Capital Markets, a Canadian merger-advisory firm, in 2010.
The company currently operates in capital markets as well as wealth management and has offices in North America, Europe and Asia.
